Reversal of benztropine toxicity by physostigmine.
D001921:Brain / Q000187:drug effects; D002746:Chlorpromazine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008570:Memory, Short-Term / Q000187:drug effects; D010276:Parasympatholytics / Q000009:adverse effects*; D010546:Perphenazine / Q000627:therapeutic use; D010830:Physostigmine / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D013881:Thioridazine / Q000627:therapeutic use
D010276:Parasympatholytics; D010830:Physostigmine; D010546:Perphenazine; D013881:Thioridazine; D007099:Imipramine; D002746:Chlorpromazine